Orthotopic liver transplantation in rats is an indispensable experimental model for biomedical research. Here we present our surgical procedures for orthotopic rat liver transplantation with hepatic arterial reconstruction using a 50% partial graft.
Orthotopic liver transplantation (OLT) in rats using a whole or partial graft is an indispensable experimental model for transplantation research, such as studies on graft preservation and ischemia-reperfusion injury 1,2, immunological responses 3,4, hemodynamics 5,6, and small-for-size syndrome 7. The rat OLT is among the most difficult animal models in experimental surgery and demands advanced microsurgical skills that take a long time to learn. Consequently, the use of this model has been limited. Since the reliability and reproducibility of results are key components of the experiments in which such complex animal models are used, it is essential for surgeons who are involved in rat OLT to be trained in well-standardized and sophisticated procedures for this model.
While various techniques and modifications of OLT in rats have been reported 8 since the first model was described by Lee et al. 9 in 1973, the elimination of the hepatic arterial reconstruction 10 and the introduction of the cuff anastomosis technique by Kamada et al. 11 were a major advancement in this model, because they simplified the reconstruction procedures to a great degree. In the model by Kamada et al., the hepatic rearterialization was also eliminated. Since rats could survive without hepatic arterial flow after liver transplantation, there was considerable controversy over the value of hepatic arterialization. However, the physiological superiority of the arterialized model has been increasingly acknowledged, especially in terms of preserving the bile duct system 8,12 and the liver integrity 8,13,14.
In this article, we present detailed surgical procedures for a rat model of OLT with hepatic arterial reconstruction using a 50% partial graft after ex vivo liver resection. The reconstruction procedures for each vessel and the bile duct are performed by the following methods: a 7-0 polypropylene continuous suture for the supra- and infrahepatic vena cava; a cuff technique for the portal vein; and a stent technique for the hepatic artery and the bile duct.
1. Basic Techniques and Common Procedures
2. Presurgical Preparation
3. Donor Operation
The schema of the removal of the liver from the donor rat is shown in Figure 2. This procedure requires approximately 30-35 min.
4. Ex vivo Graft Preparation
All procedures for the liver graft are performed in the metal cup filled with ice-cold HTK solution. The ex vivo graft preparation requires approximately 30 min.
5. Recipient Operation
The schema of the graft implantation in the recipient rat is shown in Figure 9. The recipient operation requires 60-70 min, which includes 10-11 min of anhepatic time and approximately 23-24 min of IHVC clamping time.
6. Postoperative Treatment and Follow-up
Immediately after the operation, treat the recipient rat with a subcutaneous injection of cefuroxime sodium (16 mg/kg) and buprenorphine (0.1 mg/kg) in a total of 1.5 ml of normal saline solution. Allow the rat to recover for 60 min in a special intensive care unit cage with warmed air (30-35 °C) and an oxygen supply. Inject buprenorphine (0.1 mg/kg) subcutaneously as an analgesic every 12 hours for 3 days. Afterward move the rat to a normal cage, and provide ad libitum access to water and food.
All recipient rats (n = 20) survived without apparent complications until planned euthanasia for blood sampling at 1, 3, 24, and 168 hr (7 days) after portal reperfusion (n = 5 at each time point). The blood samples were collected from the IHVC by a direct puncture with a 27-gauge needle. Following the centrifugation at 5,340 x g for 10 min, the serum samples were obtained and analyzed for alanine aminotransferase (ALT) levels, which reflect the degree of hepatocellular damage after transplantation. The time-course of changes in serum ALT levels is shown in Figure 16. The ALT levels reached a peak at 24 hr (mean ± standard deviation: 212.6 ± 67.9 IU/L) and then declined to within normal limits at 168 hr (33.6 ± 6.8 IU/L).
Figure 1. A cuff for the portal vein (PV) from a 14-gauge catheter, and stents for the hepatic artery (HA) and bile duct (BD) from 24-gauge catheters.
Figure 2. Schema of the removal of the liver from the donor rat. BD, bile duct; HA, hepatic artery; IHVC, infrahepatic vena cava; PV, portal vein; SHVC, suprahepatic vena cava.
Figure 3. Donor operation. a. The rat is placed on a heating pad with a magnetic fixator retraction system. The abdomen is opened by a midline incision with bilateral extensions. b. Insertion of the stent into the bile duct. c. Perfusion of the liver through the portal vein. Abbreviations are explained in Figure 2.
Figure 4. Attachment of a cuff to the portal vein. a,b. The DeBakey Bulldog clamp that grasps the portal venous trunk is placed over the metal cup. The cup is mounted in the plastic box filled with crushed ice. c. The portal vein is put through the cuff. d. The wall of the portal vein is everted over the cuff with the stump of the splenic vein outside the cuff at the 7 o’clock position and an extension of the cuff at the 12 o’clock position. e. The portal vein is secured with a circumferential 6-0 silk thread on the cuff. The black arrows indicate the stump of the splenic vein.
Figure 5. Ex vivo insertion of a stent into the hepatic artery. a. The liver is fixed by clamping both edges of the diaphragm, and the hepatic artery is pulled straight by holding the thread ligated for the artery. b. The anterior wall of the small incision on the hepatic artery is held with a straight micro forceps. c, d. The stent is inserted into the hepatic artery and secured with a 6-0 silk thread.
Figure 6. The schema of ex vivo 50% liver resection. Lobes in gray color are removed. ACL, anterior caudate lobe; PCL, posterior caudate lobe; LLL, left lateral lobe; LML, left portion of the median lobe; RML, right portion of the median lobe; SRL, superior right lateral lobe; IRL, inferior right lateral lobe.
Figure 7. Ex vivo 50% liver resection. a. Ligation of the pedicle of the posterior caudate lobe. b. Ligation of the pedicle of the left portion of the median lobe. c. The liver before 50% resection. d. The liver after 50% resection.
Figure 8. Ex vivo plasty of the suprahepatic vena cava. a. The liver is fixed by clamping both edges of the diaphragm with the mosquito forceps. b. Stay sutures with 7-0 polypropylene are attached at both corners.
Figure 9. Schema of the graft implantation in the recipient rat. The reconstruction procedures are performed for the supra- and infrahepatic vena cava (SHVC and IHVC) with a 7-0 continuous suture, the portal vein (PV) by a cuff technique, and the hepatic artery (HA) and bile duct (BD) by a stent technique.
Figure 10. Recipient operation until the removal of the native liver. a. The abdomen is opened by a midline incision. b. The right adrenal vein is ligated. c. The native liver is excised. Abbreviations are explained in Figure 2.
Figure 11. Anastomosis of the suprahepatic vena cava. a, b. The peripheral vascular clamp for the suprahepatic vena cava is fixed in a lump of oil-based clay. The stay sutures at both corners are maintained with gentle traction superiolaterally to widen the anastomosis. c. Continuous intraluminal suture of the posterior row in progress. d. Continuous suture of the anterior row in progress.
Figure 12. Reconstruction of the portal vein. a, b. The mosquito forceps clamping the portal vein is fixed in the oil-based clay and pulled toward the liver hilum. c-f. Insertion of the cuff into the portal vein.
Figure 13. Reconstruction of the hepatic artery. a, b. Insertion of a stent into the recipient common hepatic artery (CHA) at the bifurcation of the proper hepatic artery (PHA) and gastroduodenal artery (GDA).
Figure 14. Anastomosis of the infrahepatic vena cava. a. The stay sutures at both corners. b. Continuous suture of the posterior row. c. Continuous suture of the anterior row. d. Reperfusion of the infrahepatic vena cava. Abbreviations are explained in Figure 2.
Figure 15. All the reconstruction procedures are finished. Abbreviations are explained in Figure 2.
Figure 16. Postoperative time-course of changes in serum alanine aminotransferase (ALT) levels (n = 20; n = 5 at each time point). Data are expressed as means with error bars that indicate standard deviations. The ALT levels reached a peak at 24 hr (212.6 ± 67.9 IU/L) and then declined to within normal limits at 168 hr (33.6 ± 6.8 IU/L).
The first model of rat OLT was reported by Lee et al. in 1973 9, in which all vessels including the hepatic artery were reconstructed by a hand-sewn method and the extracorporeal portosystemic shunt was used. This model was technically complicated and difficult to perform. The next model was one without hepatic arterial reconstruction and the extracorporeal shunt, developed by the same authors 10 in 1975. Subsequently in 1979, Kamada et al. introduced the cuff anastomosis technique for the model without hepatic rearterialization 11. With these modifications, OLT in rats was simplified with a shortened anhepatic time in recipient operations and has been widely used as an accepted experimental model.
However, there has been considerable controversy since then over the significance of hepatic arterialization in rat OLT 8 because the arterialization was a demanding task but did not affect survival after transplantation. Numerous studies on hepatic arterialization using various reconstruction techniques have been reported 8, such as an aortic segment-to-aorta anastomosis 3,9,17, a cuff anastomosis technique 18,19,20, a telescoping technique 5, a stent technique 13,16, and a sleeve anastomosis technique 12,21-23. While the technique for rat OLT is still not standardized today, the arterialized model has been increasingly favored in terms of its physiological superiority 8,12,13,14. Among the above-mentioned techniques, a stent technique that was simple and fast to perform was reported by Lehmann et al. 16 in 2005. The study showed excellent results: no occlusion rate was observed in the reconstructed hepatic artery at 8 hr, 24 hr, and 6 months after reperfusion. We therefore adopted this technique for hepatic arterialization.
We perform a hand-sewn anastomosis for the reconstruction of the SHVC and IHVC. This method provides the anastomotic site with an optimal physiological condition, which leads to the reduced incidence of thrombosis 8, and is the best microsurgery simulation and training for surgeons. In addition, the anastomosis can be possible even with short vessel stumps. Concerning the anastomosis of IHVC, this method does not require a long IHVC on the graft side compared with the cuff anastomosis technique. Therefore, when the donor renal vein is dissected to make the graft IHVC long, this method is applicable to transplantation of a small graft that necessitates a long IHVC, such as a 30% graft that consists of right lateral and caudate lobes with a short intrahepatic vena cava without SHVC 2.
Regarding the techniques of liver resection in rats, to date several methods have been reported; the two major techniques are the classical mass ligature technique and the vessel-oriented technique 24. We perform the classical ligature technique for 50% liver resection15, but under a surgical microscope to make the procedure finer, and to avoid damage to the remaining lobes and structures.
We described the representative results from the recipient rats in our model; the rats survived during the 7-day observation period without apparent complications. The model can be modified for different purposes of experiments by choosing the different settings, such as prolonged cold storage, prolonged warm ischemia that includes donation after cardiac death, and the usage of smaller liver grafts or grafts from experimental models of liver injury or diseases.
In our experience, there are three key factors throughout the procedures that can affect the survival after transplantation, the most reliable parameter for outcomes of rat OLT: the amount of blood loss; the operation time, especially clamping time of the portal vein and IHVC; and the adequacy of the reconstruction of each vessel, which could result in stenosis, thrombosis, or bleeding. In a training period of this model, most of the failures could probably be related to those factors. In this video article, we present step-by-step instructions for the surgical procedures for our rat model of partial OLT with hepatic arterial reconstruction. While a rat model of OLT is complicated and requires advanced microsurgical skills, this article provides plenty of practical information, which should serve as a good guide for the training and learning of this model. Learning this model efficiently is particularly important for shortening the learning period, reducing the number of animals and costs needed for practice, and later reproducing reliable results in experiments. This is in line with the 3Rs concept (replacement, reduction, and refinement) of animal experiments, which was postulated by Russell and Burch in 1959 25.
The authors have nothing to disclose.
The authors thank Pascal Paschenda and Mareike Schulz for their technical assistance.
Name | Company | Catalogue number | Comments |
Surgical microscope | Leica | M651 | |
Light source | Schott | KL1500LCD | |
Cotton swabs | NOBA Verbandmittel | 974202 | |
Gauze swabs (5×5 cm) | Fuhrmann | 10002 | |
povidone-iodine solution | Mundipharma | 6108022.00.01 | |
Oil-based clay | Debika corporation | 090148 | |
TachoSil | Takeda Pharmaceuticals International GmbH | EU/1/04/277/001-004 | Applied to resected liver surface |
Scalpel blade No. 11 | Pfm medical | 200130011 | Preparation of cuff and stents |
14-gauge catheter | B. Braun | 4268210S | Cuff for PV |
18-gauge catheter | B. Braun | 4268130S | Perfusion via PV |
24-gauge catheter | B. Braun | 4269071S | Stent for BD and HA |
4-0 silk suture | Resorba | H3F | Liver resection |
6-0 silk suture | Resorba | H1F | |
7-0 Prolene (polypropylene) suture | Ethicon | 8701H | SHVC and IHVC |
4-0 Vicryl suture | Ethicon | V304H | Abdominal closure |
5-ml syringe | Terumo | SS+T05ES1 | Back pillow |
Heating pad | Thermo | 190 x 260 mm | |
Magnetic fixator retraction system | Fine Science Tools Inc. | 18200-01 18200-02 18200-03 18200-12 |
|
Cold water bath | Huber | 740.000X | Graft preservation |
Bipolar forceps | Söring | MBC-200 | |
Mosquito forceps | BONIMED | 451-476-03 | Two pairs used |
Adson micro forceps | Dimeda | 10.176.12 | |
Curved micro forceps | AESCULAP | FD281R | |
Straight micro forceps | Bonimed | 451-476-03 | |
Curved micro scissors | Medicon | 05.15.83 | |
Straight micro scissors | AESCULAP | FD12 | Fine incision |
Scissors | AESCULAP | BC211W | |
Micro needle holder | AESCULAP | FD241R | Reconstruction |
Mayor-Hegar Needle holder | Mizuho Ikakogyo | 06-798-00 | Abdominal closure |
DeBakey Bulldog clamp (straight) | ULRICH | CV3054 | |
DeBakey Bulldog clamp (curved) | CODMAN | 37-1062 | |
Satinsky clamp | Mizuhoika | 09-230-24 | |
Peripheral vascular clamp | Teleflex Medical | 353494 | Recipient SHVC |
Micro vessel clamp (disposable) | AROSurgical Instruments Corporation | TKM-1-60 g | PV, graft IHVC, and recipient HA |
Micro vessel clamp (metal) | Fine Science Tools Inc. | 18052-01 | Recipient IHVC |
Lactated Ringer solution | Fresenius Kabi | 6150917.00.00 | |
Normal saline solution | DeltaSelect | 1299.99.99 | |
HTK solution | Dr. Franz Köhler Chemie GmbH | 31268.00.00 | Preservation solution |
Heparin-Natrium | Ratiopharm | 5394.02.00 | 500 IU before graft perfusion |
8.4% sodium bicarbonate | Fresenius Kabi | 4399.97.99 | 0.5 ml after reperfusion |
5% Glucose solution | B. Braun | 6714567.06.00 | 1.0 ml after reperfusion |
Cefuroxim sodium | Fresenius Kabi | 38985.01.00 | Antibiotic, 16 mg/kg |
Buprenorphine | Essex Pharma | 997.00.00 | Painkiller, 0.1 mg/kg |
Intensive Care Unit Cage | Brinsea Products Ltd. | Vetario S10 | Postoperative care |